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ALTHOUGH attempts have been made to induce gastric adenocarcinomas in
laboratory animals by parenteral administration of carcinogens, none has been
successful (Klein and Palmer, 1941; Barrett, 1946; Hartwell, 1951). It occurred
to Ray and Peters (1951, and unpublished data) that one might be able to sub-
ject the glandular mucosa of the stomach to a carcinogen by administering a
suitable compound which would be selectively secreted by the gastric glands.
Thus, it was reported that fluorene-2-azo-2', 4'-dihydroxybenzene (Compound III),
a derivative of the carcinogen 2-aminofluorene, was found in the gastric juice
of the rat following intraperitoneal injection (Ray and Peters, 1951). All the
animals in the latter experiments had been operated on several hours prior to
injection time, and the intestine in the region of the pylorus ligated to eliminate
the possibility of back-flow into the stomach. In addition, each rat was injected
with histamine. In the dog, which has been employed frequently for studies
in gastric physiology, histamine is known to enhance the flow of gastric juice.
However, Friedman (1943) reported that histamine did not stimulate secretion
in the rat's stomach.
In the present experiments the ability of the gastric mucosa to secrete Com-
pound III was investigated in the rat as well as in the mouse and guinea-pig.
The influence of histamine on gastric secretion and on blood volume in these
species also was studied.
MATERIALS AND METHODS.
Sprague-Dawley male rats weighing 324 to 500 g., strain A (Bar Harbor) male
mice weighing 23 to 30 g., and stock male guinea-pigs weighing 362 to 480 g.,
were employed in these experiments. The rats and mice were maintained on
Purina Laboratory Chow pellets prior to the start of the experiments, while the
guinea-pigs were fed Purina Rabbit Laboratory Chow pellets and received in
addition a daily supplement of lettuce. Animals were fasted 48 hours, but were
allowed tap water up to the time of operation, after which both food and water
were withheld. A laparotomy was performed on each animal using ether anesthe-
sia for rats and guinea-pigs and nembutal for mioe, and a loop of the intestine
adjacent to the pylorus ligated. The abdominal cavity was closed with nylon
sutures and each animal returned to its original cage. The animals were not
treated further until 3 to 3- hours following the laparotomy by which time all
had emerged from the anesthesia. Some of the animals were injected with a
solution ofhistamine dihydrochloride (obtained from Eastman Kodak Co., Roches-GASTRIC SECRETION OF A CARCINOGEN
ter, N.Y.) in a concentration of 0-6 mg. per ml., each receiving 0-002 mg. ofhista-
mine per g. of body-weight. While some of the animals were injected subou-
taneously, others received histamine intraperitoneally. Fluorene-2-azo-2', 4'-
dihydroxybenzene, Compound III (prepared in this Laboratory), dissolved in
propylene glycol, was injected intraperitoneally and at a concentration of 1-25
mg. per ml. of solvent. Each animal received 0-0125 mg. of the Compound per
g. of body-weight. Where both histamine and Compound III were injected into
the same animal, this was done simultaneously. One group of rats was injected
intraperitoneally with Toluidine Blue 0 (C.I. 925) (obtained from National Aniline
Division, Allied Chem. and Dye Corp., New York, N.Y.) dissolved in propylene
glycol, while another group was injected intraperitoneally with an aqueous solu-
tion of this dye. The Toluidine Blue 0 was given in the same concentration and
on the same body-weight basis as described for Compound III. Six rats were
injected intravenously with 0-0025 ml. per g. of body-weight of a 0.5 per cent
aqueous solution of Toluidine Blue 0. .1
Animals were anesthetized i an hour following the time of injection and a
blood sample withdrawn either by heart puncture or from the aorta. The eso-
phagus was then ligated below the diaphragm, and the stomach removed and
rinsed in Ringer's solution maintained at room temperature. The gastric contents
were collected in a calibrated centrifuge tube and the volume recorded. The
pH of the contents as well as of the gastric mucosa was obtained with Hydrion
paper. The stomach contents were diluted 1: 1 with acetone, stirred, and centri-
fuged for 10 minutes at 2000 r.p.m. The supernatant was withdrawn and a 1 ml.
aliquot diluted with acetone to 10 ml. This was stored at 50 to 100 C. overnight
following which it was centrifuged 20 minutes at 2000 r.p.m., and the supernatant
removed for spectrophotometric analysis. In some rats the intestinal tract was
removed and the contents collected. These as well as the blood samples were
analyzed in the same manner as the stomach oontents. For the standard curve,
1 ml. of propylene glycol containing 0-125 mg. of Compound III was treated
exactly as the samples of stomach contents. Where Purina Laboratory Chow
pellets were analyzed the material was ground and a 5 ml. sample used. Feces
were dried and ground, and a 3 ml. sample tested. Both the food and
feces samples were extracted in the same manner as the gastric contents. An
acetone blank was used for all determinations. In the case of gastric samples,
the pH of the blank was adjusted to that of the sample using HC1. The same
acetone was used throughout the experiments and was redistilled prior to use.
A Beckman Model DU Spectrophotometer was employed in making the measure-
ments. The procedures outlined above duplicate those employed in the experi-
ments of Ray and Peters (1951).
The ratio of formed elements in the blood (cell volume) to plasma was deter-
mined by hematocrit readings using the Wintrobe and Lansberg method
(Gradwohl, 1948).
The animals were divided on the basis of treatment intothefollowing groups:
Group 1-5 rats, 14 mice, 5 guinea-pigs-injected subcutaneously with the
histamine solution and intraperitoneally with the solution of Compound III.
Group II-3 rats-injected subcutaneoulsy with the histamine solution and
intraperitoneally with propylene glycol.
Group III-10 rats, 9 mice, 5 guinea-pigs-injected subcutaneously with
distilled water and intraperitoneally with propylene glycol.
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Group IV-6 rats-no injections.
Group V-6 rats-injected intraperitoneally with the histamine solution and
intraperitoneally with Compound III in propylene glycol. Three of the rats
were used for intestinal content analysis only.
Group VI 6 rats injected intraperitoneally with the histamine solution and
intraperitoneally with propylene glycol. Three ofthe rats were used for intestinal
content analysis only.
Group VII-4 rats-injected subcutaneously with the histamine solution and
intraperitoneally with Toluidine Blue 0 in propylene glycol.
Group VIII-2 rats--injected intraperitoneally with the histamine solution and
intraperitoneally with Toluidine Blue 0 in water.
RESULTS AND DISCUSSION.
In the rat the influence of histamine on gastric secretion may be observed
from a comparison of those animals which were injected with the compound
(Groups I, II, V, VI, VII, VIII) and those which received none (Groups III, IV).
The 20 animals given histamine averaged 403 g. compared to 389 g. for those
not injected with histamine. One-halfhour following administration ofhistamine
the rats showed an average volume of gastric contents of5-4 ml. whereas among the
rats not injected with histamine the average was 5-3 ml. The average volume
of gastric contents for individual rat groups may be seen in Table I.
TABLE I.-Summary of Data from Gastric Content Analyses and Blood
Analyses in Duodenum-Ligated Animals.
Group Total pH Vol. of gastric Hematocrit Species number. anumnals (average), contents values
(number). * (average ml.). (average).
Rat . . I . 5 . 3-7 . 6-0 . 67
9,, . . II . 3 . 4.5 . 5.5 . 68
III . 10 . 3.9 . 4-5 . 65
IV . 6 . 3.5 . 6-5 . -
V . 3 . 4-2 . 4 0 . 72
VI . 3 . 3-6 . 6*0 . 72
VII . 4 . 3.0 . 5*6
VIII . 2 . 4 0 . 4-3
Mouse. . I . 14 . 5*3 . 0 4
III . 9 . 6 0 . 0.5
Guinea pig . I . 5 . 2-5 . 16-5 . 63
VP . . III . 5 . 2 5 . 9 2 . 60
Among 14 mice (average weight 22 g.) injected with histamine, the gastric
contents averaged 0 4 ml. (Group I, Table I) Compared to this, the average
volume of gastric contents from 9 mice (average weight 25 g.) which did not
receive histamine was 05 ml. (Group III).
In histamine treated guinea-pigs (Group I) the average volume of gastric
contents was 16-5 ml., whereas in Group III, where histamine was not injected,
the average volume was 9-2 ml. Body-weights for the animals in these two groups
averaged 436 g. and 409 g. respectively.
Although injection of histamine into dogs as well as other animals stimulates
the flow ofgastric secretion, this was not observed among rats or mice in the pres-
ent experiments. Thus the volume of gastric contents recovered after - an hour
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from rats and mice given histamine was about the same as that obtained from
other animals not under the influence of this compound. Friedman (1943) pre-
viously reported that gastric secretion in young albino rats was not affected by
the injection of varying doses of histamine. It was suggested that this might be
due to a rapid rate of disappearance of histamine from rat blood as well as an
apparent inability of the rat's stomach to retain histamine. While injection of
histamine did not influence gastric secretion in the rat or mouse, in the guinea-
pig a definite stimulation was observed. Inasmuch as the the guinea-pig, like
the dog, is considered to be susceptible to histamine stimulation, an enhancement
of gastric secretion following injection in this species was anticipated.
The proportion of formed elements to plasma in the blood was determined
for rats and guinea-pigs but not for mice in several of the groups. These results
are listed in Table I under hematocrit values. It will be observed that among the
rats which received histamine (Groups I, II, V, VI), an average value of 69 was
obtained. Whentheratswerenotinjectedwithhistamine(Group III),thehemato-
crit value averaged 65. Neither the pH of the stomach contents nor that of the
gastrio glandular mucosa was altered significantly by the administration
of histamine.
In the rat a normal hematocrit value of 45-8 has been reported for males of
the Sprague-Dawley strain (Gardner, 1947a). This value was confirmed in our
Laboratory. The operated rats in the present experiments showed significantly
higher hematoorit values (Table I) than untreated rats. Thus the histamine
appeared to have no additional effect on the hemoconcentration observed in all
operated animals.
In untreated male guinea-pigs a hematocrit value of 42 has been reported
(Gardner, 1947b). Examination ofthe blood oftreated guinea-pigs in our experi-
ments disclosed a significantly higher hematocrit value in every animal. Among
those guinea-pigs which received histamine and Compound III in propylene
glycol, the volume of packed cells was 63 per cent, while a value of 60 per cent
was obtained for those not given histamine. Thus, in guinea-pigs, as in rats,
where the intestine has been ligated, histamine injection does not appear to in-
fluence blood-cell-volume-ratios. Inasmuch as the animals in the present experi-
ments may have been under the influence of shock as a result of preliminary
operative procedures, this could account for the observed hemoconcentration in
the absence of administered histamine (Gradwohl, 1948, Selye, 1950).
Gastric Contents.
In Fig. 2 are plotted the results of spectophotometric analyses of gastric ex-
tracts from 8 rats. Only 1 treated animal, No. 5, shows results comparable to
those of Ray and Peters (1951). The stomach contents of treated animal No. 4
also shows a slightly greater absorption than the controls. The rest, both experi-
mental and control, except No. 1, show considerable generalized absorption with
some selective increase in the same general region shown by Compound III (Fig.
1). Fig. 3 shows 7 rats, 4 controls and 3 treated. One of the treated animals,
No. 28, shows somewhat greater absorption than the rest, comparable to animal
No. 4 in Fig. 2. These, No. 4 and 28, cannot be considered satisfactory evidence
for Compound III in view of the considerable absorption in the same region by
the untreated controls. In Fig. 4 results for 7 mice are shown. Two of the
treated mice show absorption similar to those previously reported for rats by
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Ray and Peters (1951). The control and 4 treated animals show no selective
absorption in the region in question.
Similar analyses, using 5 guinea-pigs ofGroup I and 1 guinea-pig corresponding
to Rat Group II, showed no definite peaks in the range between 375 and 400m,tt.
Although animals were fasted 48 hours prior to the start of operations no
precautions were taken to prevent coprophagy, since it was our intention to dupli-
cate the oonditions which prevailed in the experiments of Ray and Peters (1951).
When gastric contents were collected, it was observed that in addition to fluids
there also was present a varying amount of solids. Although some of this may
have been due to residual food, it is more likely that ingestion offeces was respon-
sible. Compound III has a maximum at 400 m,u., Purina Laboritory Chow 410
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FIG. 1-Spectrophotometric curves for Compound III (1); Purina Laboratory Chow pellets (2);
rat feces (3); and mouse feces (4).
m,t., rat feces 405 m,u., and mouse feces 410 m,u., (Fig. 1). Ifthe absorption found
in the stomach contents were caused entirely by either food or feces, the peak
shouldnot be so uniformly displaced to the shorter wave-lengths (Fig. 2, 3, and 4).
These may contribute to the general absorption, although the results with mice
(Fig. 4) seem to eliminate the food since both rats and mice ate Purina Chow.
It is possible that Compound III injected intraperitoneally, in some way may
cause secretion bythestomachofmaterial absorbing inthered endofthe spectrum.
Ifso, this is not specific for Compound III, since analysis ofgastric contents from
rats injected intraperitoneally with Toluidine Blue 0 in propylene glycol (maxi-
mum absorption 620 m,t.) gave similar results. Intense absorption occurred at
380 m/t. in the stomach contents but none at 620 m,u. On the other hand, intra-
peritoneal injection of Toluidine Blue 0 in aqueous solution (Group VIII) as well
as intravenous injection of a 0 5 per cent solution of the same dye resulted in the
recovery of material from the stomach absorbing in the region of 620 mit.
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Since gastric analyses from control rats gave generalized absorption over the
same range as gastric extracts from animals receiving Compound III, it was not
possible to establish the presence of this compound in the gastric contents. It
was therefore considered ofinterest to determine whether Compound III oould be
recovered from other sites.
370 385
Wavelength
FiG. 2-Spectrophotometric curves of gastric extracts. Curve numbers represent data from
rats of the following groups: No. 1, 2, 3, 4, 5-Group I; No. 6-Group II; No. 13-Group
III; No. 18-not included in any Group-rat injected subcutaneously withhistamine solution
alone. Solid lines represent animals given Compound III.
Analyses ofblood from ratsinjected with Compound III revealed no compound
by a method which was shown to detect 001 mg. per ml. ofblood when Compound
III was added to normal blood samples in vitro. This, however, proved ofdoubt-
ful significance because Toluidine Blue 0 was also absent from the blood i an
hour after it had been injected intravenously.
At autopsy the entire abdominal oavity in the rat was observed to be stained
with Compound III. This wasespeciallyintense for adiposetissue. Examination
of urine in the bladder showed no color.
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FIG. 3-Spectrophotometric curves of gastric extracts. Curve numbers represent data from
rats of the following groups: No. 19, 20-Group IV; No. 27, 28, 29-Group V; No. 30, 31-
Group VI. Solid lines represent animals given Compound III.
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FIG. 4-Spectrophotometric curves. of gastric extracts. Curve numbers represent data from
miceofthefollowinggroups: No. 1,2,3,4,5, 6-Group I; No. 7-GroupII. Solidlinesrepre-
sent animals given Compound III.
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An attempt to establish the presence of Compound III in intestinal contents
also gave inconclusive results. Intestinal extracts from rats injected with this
compound (Group V) gave absorption maxima at 340 m,t. and 400 m,. These
values were identical with the absorption maxima observed in control animals
receiving propylene glycol (Group VI). Spectrophotometric curves for these
data are given in Fig. 5. These results indicate the difficulty encountered in
370 '
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FIG. 5.-Spectrophotmetric curves ofintestinal extracts. Curve numbers represent data from
rats ofthe following groups: No. 53,54,55-Group V; No. 56,57,58-GroupVI. Solid lines
represent animals given Compound III.
attempting to establish the presence of Compound III in intestinal extraots using
spectrophotometric analyses. On the other hand, the presence of Toluidine Blue
O may be established by spectrophotometric analysis since intestinal contents
give no peaks in the region of maximum absorption ofthis dye. It is of interest
that such analysis from rats injected intraperitoneally with an aqueous solution
of Toluidine Blue 0 failed to reveal this blue dye.
Ray and Peters (1951) reported that gastric extracts from 3 out of 3 rats
treated with Compound III showed substantial absorption at 400 mru. In the
present experiments only 1 rat out of 15 showed similar results, while 2 fell in
an intermediate, doubtful category. Two of 6 treated mice showed selective
absorption, while the other 4 and 1 control showed none. Since Toluidine Blue
18§
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0 in aqueous solution was readily secreted by the stomach when injected intrav-
enously or intraperitoneally but was not secreted when administered intraperi-
toneally in propylene glycol, it can be concluded that Compound III dissolved
in propylene glycol stands little chance of being secreted by the rat's stomach.
SUMMARY.
Rats, mice and guinea-pigs were fasted 48 hours, then operated on and the
duodenum ligated in the region of the pylorus. Although animals from each
species were injected with histamine, recovery ofgastric contents 2 an hour there-
after showed no apparent effect of this compound on volume of secretion except
in the guinea-pig. A study of blood cell volume in operated rats and guinea-pigs
revealed hemoconcentration whether ornot an animal was injected with histamine.
Following intraperitoneal injection of fluorene-2-azo-2', 4'-dihydroxybenzene
(Compound III) in propylene glycol into rats, mice, and guinea-pigs, it was not
possible to determine conclusively the presence of this compound in the gastric
contents. Inasmuch as Toluidine Blue 0 also did not appear in the stomach
following similar injection but was secreted when an aqueous solution was injected
intravenously or intraperitoneally, it is probable that the present method of
administration of Compound III is not suitable for an investigation of gastric
secretion with this dye.
We are indebted to Hilda Banks, Dorothy Bowland, William Gryder, Marjorie
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